Diagnostic drives therapeutic marketing strategy

Diagnostic drives therapeutic marketing strategy Small companies that develop diagnostics have often felt they had no choice but to license technology to their larger brethren. Ostex International Inc. has taken a different path, finding a pharma company that believes Ostex's immunoassay can help groom the market for a therapeutic product.

Under the deal, Ostex signed a cooperative agreement with Merck & Co. Inc. to develop the Osteomark immunoassay as a means of diagnosing the rate of bone resorption. ...